![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
1. 5a35gqs15r
2. 252042-59-4
3. Phosphorylated Hexaacyl Disaccharide
4. [(2r,3s,4r,5r,6r)-2-(hydroxymethyl)-3-phosphonooxy-5-[[(3r)-3-tetradecanoyloxytetradecanoyl]amino]-6-[(2r,3s,4r,5r)-2,3,4-trihydroxy-6-oxo-5-[[(3r)-3-tetradecanoyloxytetradecanoyl]amino]hexoxy]oxan-4-yl] (3r)-3-tetradecanoyloxytetradecanoate
5. D-glucose, 2-deoxy-6-o-(2-deoxy-3-o-((3r)-1-oxo-3-((1-oxotetradecyl)oxy)tetradecyl)-2-(((3r)-1-oxo-3-((1-oxotetradecyl)oxy)tetradecyl)amino)-4-o-phosphono-.beta.-d-glucopyranosyl)-2-(((3r)-1-oxo-3-((1-oxotetradecyl)oxy)tetradecyl)amino)-
6. D-glucose, 2-deoxy-6-o-(2-deoxy-3-o-((3r)-1-oxo-3-((1-oxotetradecyl)oxy)tetradecyl)-2-(((3r)-1-oxo-3-((1-oxotetradecyl)oxy)tetradecyl)amino)-4-o-phosphono-beta-d-glucopyranosyl)-2-(((3r)-1-oxo-3-((1-oxotetradecyl)oxy)tetradecyl)amino)-
Molecular Weight | 1730.4 g/mol |
---|---|
Molecular Formula | C96H181N2O21P |
XLogP3 | 29.1 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 21 |
Rotatable Bond Count | 92 |
Exact Mass | 1730.29280262 g/mol |
Monoisotopic Mass | 1729.28944778 g/mol |
Topological Polar Surface Area | 347 Ų |
Heavy Atom Count | 120 |
Formal Charge | 0 |
Complexity | 2500 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 12 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |